The drug sensitivity panel is back and it explains a lot. His cancer is CD8+ peripheral T-cell lymphoma, stage IIIa, and it is largely resistant to the CHOP drugs we started with (vincristine scored 0.15 of 1.00). The best bets are asparaginase at 0.60, mitoxantrone at 0.59, and lomustine at 0.55. The plan is changing, and honestly, having a map feels better than guessing.